dc.contributor.author	ZANOTTI-FREGONARA, Paolo
dc.contributor.author	MORGAT, Clément
hal.structure.identifier	Centre d'Etudes Nucléaires de Bordeaux Gradignan [CENBG]
dc.contributor.author	CHAMPION, Christophe
dc.contributor.author	HINDIÉ, Elif
dc.date.issued	2017
dc.description.abstractEn	Letter about the article by Sansovini et al. “Sansovini M, Severi S, Ianniello A, Nicolini S, Fantini L, Mezzenga E, Ferroni F, Scarpi E, Monti M, Bongiovanni A, Cingarlini S, Grana CM, Bodei L, Paganelli G. Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-DOTATATE. Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):490-499.”
dc.language.iso	en
dc.title.en	Predicting the outcome of peptide receptor radionuclide therapy in neuroendocrine tumors: the importance of dual-tracer imaging
dc.type	Article de revue
dc.identifier.doi	10.1007/s00259-017-3667-7
dc.subject.hal	Physique [physics]
bordeaux.journal	Eur.J.Nucl.Med.Mol.Imaging
bordeaux.page	1095-1096
bordeaux.volume	44
bordeaux.issue	6
bordeaux.peerReviewed	oui
hal.identifier	hal-01744015
hal.version	1
hal.popular	non
hal.audience	Internationale
hal.origin.link	https://hal.archives-ouvertes.fr//hal-01744015v1
bordeaux.COinS	ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Eur.J.Nucl.Med.Mol.Imaging&rft.date=2017&rft.volume=44&rft.issue=6&rft.spage=1095-1096&rft.epage=1095-1096&rft.au=ZANOTTI-FREGONARA,%20Paolo&MORGAT,%20Cl%C3%A9ment&CHAMPION,%20Christophe&HINDI%C3%89,%20Elif&rft.genre=article

Fichier(s) constituant ce document

Fichiers	Taille	Format	Vue
Il n'y a pas de fichiers associés à ce document.

Predicting the outcome of peptide receptor radionuclide therapy in neuroendocrine tumors: the importance of dual-tracer imaging